Replies to post #4932 on Capricor Therapeutics Inc (CAPR)

[GS1]

There won't be any trials expanded access refers to treatment directly to patients outside any trial.

Also IND protocol is for existing IND application. So I think they already filed IND for which they received ok from FDA to treat patients.